Cancer Incidence and Mortality among Asians and Pacific Islander Individuals, New York City, 2016-2020
Source: New York State Cancer Registry
| Site of Cancer | Incidence | Mortality | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Males and Females | Males | Females | Males and Females | Males | Females | |||||||||||||
| Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | Average Annual Deaths | Rate per 100,000 Population | 95% CI | Average Annual Deaths | Rate per 100,000 Males | 95% CI | Average Annual Deaths | Rate per 100,000 Females | 95% CI | |
| All Invasive Malignant Tumors | 5,076.6 | 350.7 | 346.3-355.2 | 2,380.0 | 357.2 | 350.6-363.9 | 2,696.6 | 347.3 | 341.4-353.3 | 1,243.8 | 89.4 | 87.1-91.7 | 680.6 | 109.3 | 105.6-113.2 | 563.2 | 73.5 | 70.8-76.3 |
| Oral cavity and pharynx | 164.6 | 11.2 | 10.4-12.0 | 104.8 | 15.3 | 14.0-16.7 | 59.8 | 7.6 | 6.7-8.5 | 32.6 | 2.2 | 1.9-2.6 | 23.2 | 3.4 | 2.8-4.1 | 9.4 | 1.2 | 0.9-1.6 |
| Esophagus | 42.0 | 2.8 | 2.5-3.3 | 33.0 | 4.8 | 4.0-5.6 | 9.0 | 1.2 | 0.9-1.6 | 25.6 | 1.8 | 1.5-2.1 | 20.0 | 3.0 | 2.4-3.7 | 5.6 | 0.8 | 0.5-1.1 |
| Stomach | 220.4 | 15.2 | 14.2-16.1 | 141.4 | 21.1 | 19.5-22.8 | 79.0 | 10.1 | 9.1-11.2 | 84.8 | 6.1 | 5.5-6.7 | 51.6 | 8.3 | 7.3-9.4 | 33.2 | 4.3 | 3.7-5.0 |
| Colorectal | 461.6 | 31.8 | 30.5-33.2 | 258.2 | 38.4 | 36.3-40.6 | 203.4 | 26.2 | 24.6-27.9 | 105.4 | 7.6 | 6.9-8.3 | 56.4 | 9.0 | 8.0-10.2 | 49.0 | 6.4 | 5.6-7.3 |
| Colon excluding rectum | 290.2 | 20.2 | 19.1-21.3 | 156.6 | 23.4 | 21.7-25.1 | 133.6 | 17.4 | 16.1-18.8 | 86.4 | 6.3 | 5.7-6.9 | 43.6 | 7.0 | 6.1-8.0 | 42.8 | 5.6 | 4.9-6.5 |
| Rectum & rectosigmoid | 171.4 | 11.7 | 10.9-12.5 | 101.6 | 15.0 | 13.7-16.4 | 69.8 | 8.8 | 7.9-9.8 | 19.0 | 1.3 | 1.1-1.6 | 12.8 | 2.0 | 1.6-2.6 | 6.2 | 0.8 | 0.5-1.1 |
| Liver / intrahepatic bile duct | 210.6 | 14.3 | 13.5-15.2 | 151.2 | 21.9 | 20.3-23.6 | 59.4 | 7.7 | 6.9-8.7 | 110.6 | 7.7 | 7.1-8.4 | 75.8 | 11.4 | 10.2-12.6 | 34.8 | 4.6 | 3.9-5.3 |
| Pancreas | 149.2 | 10.5 | 9.7-11.3 | 77.0 | 11.8 | 10.6-13.0 | 72.2 | 9.4 | 8.4-10.4 | 96.0 | 6.8 | 6.2-7.5 | 48.0 | 7.4 | 6.5-8.5 | 48.0 | 6.4 | 5.6-7.2 |
| Larynx | 24.4 | 1.7 | 1.4-2.0 | 21.8 | 3.3 | 2.7-4.0 | 2.6 | 0.3 | 0.2-0.6 | 2.6 | 0.2 | 0.1-0.3 | 2.2 | 0.3 | 0.2-0.6 | 0.4 | 0.0 | 0.0-0.2 |
| Lung and bronchus | 686.2 | 47.7 | 46.1-49.4 | 393.6 | 60.6 | 57.8-63.4 | 292.6 | 37.2 | 35.3-39.2 | 282.0 | 20.4 | 19.3-21.5 | 175.6 | 28.6 | 26.7-30.6 | 106.4 | 13.8 | 12.6-15.0 |
| Melanoma of the skin | 15.0 | 1.1 | 0.8-1.3 | 7.8 | 1.2 | 0.8-1.6 | 7.2 | 1.0 | 0.7-1.3 | 5.6 | 0.5 | 0.3-0.7 | 3.4 | 0.6 | 0.4-1.0 | 2.2 | 0.3 | 0.2-0.6 |
| Female breast | 825.2 | 106.0 | 102.7-109.3 | 72.6 | 9.4 | 8.5-10.5 | ||||||||||||
| Cervix uteri | 65.6 | 8.6 | 7.7-9.6 | 12.6 | 1.6 | 1.2-2.1 | ||||||||||||
| Corpus uterus and NOS | 180.0 | 22.3 | 20.9-23.9 | 25.0 | 3.2 | 2.6-3.8 | ||||||||||||
| Ovary | 85.4 | 11.2 | 10.1-12.3 | 32.0 | 4.0 | 3.4-4.7 | ||||||||||||
| Prostate | 404.4 | 58.0 | 55.4-60.7 | 36.0 | 6.4 | 5.5-7.5 | ||||||||||||
| Testis | 16.4 | 2.5 | 2.0-3.1 | 0.4 | 0.1 | 0.0-0.3 | ||||||||||||
| Urinary bladder (incl. in situ) | 133.2 | 9.5 | 8.8-10.2 | 105.0 | 16.6 | 15.1-18.1 | 28.2 | 3.7 | 3.1-4.3 | 20.6 | 1.6 | 1.3-1.9 | 15.6 | 2.7 | 2.2-3.4 | 5.0 | 0.7 | 0.4-1.0 |
| Kidney and renal pelvis | 149.4 | 10.1 | 9.4-10.9 | 94.2 | 13.9 | 12.6-15.2 | 55.2 | 6.9 | 6.1-7.8 | 20.6 | 1.5 | 1.2-1.9 | 14.8 | 2.4 | 1.8-3.0 | 5.8 | 0.8 | 0.5-1.2 |
| Brain and other central nervous system | 63.6 | 4.4 | 4.0-5.0 | 35.0 | 5.2 | 4.4-6.0 | 28.6 | 3.8 | 3.2-4.5 | 33.2 | 2.4 | 2.0-2.8 | 18.4 | 2.9 | 2.3-3.6 | 14.8 | 2.0 | 1.5-2.5 |
| Thyroid | 379.4 | 26.3 | 25.1-27.5 | 98.8 | 14.7 | 13.4-16.1 | 280.6 | 36.5 | 34.6-38.5 | 4.8 | 0.4 | 0.2-0.6 | 3.2 | 0.6 | 0.3-0.9 | 1.6 | 0.2 | 0.1-0.5 |
| Hodgkin lymphoma | 23.0 | 1.7 | 1.4-2.0 | 13.2 | 2.1 | 1.6-2.7 | 9.8 | 1.3 | 1.0-1.7 | 1.2 | 0.1 | 0.0-0.2 | 0.4 | 0.1 | 0.0-0.2 | 0.8 | 0.1 | 0.0-0.3 |
| Non-Hodgkin lymphomas | 198.0 | 13.9 | 13.0-14.8 | 110.2 | 16.9 | 15.5-18.4 | 87.8 | 11.3 | 10.3-12.5 | 37.6 | 2.7 | 2.3-3.1 | 24.0 | 3.8 | 3.1-4.6 | 13.6 | 1.7 | 1.3-2.2 |
| Myeloma | 63.0 | 4.3 | 3.8-4.8 | 37.4 | 5.5 | 4.7-6.4 | 25.6 | 3.3 | 2.7-3.9 | 16.8 | 1.2 | 1.0-1.5 | 9.8 | 1.6 | 1.2-2.2 | 7.0 | 0.9 | 0.6-1.3 |
| Leukemias | 126.6 | 9.2 | 8.5-10.0 | 73.2 | 11.6 | 10.4-12.9 | 53.4 | 7.3 | 6.4-8.2 | 43.0 | 3.2 | 2.8-3.7 | 26.6 | 4.5 | 3.8-5.4 | 16.4 | 2.2 | 1.7-2.7 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.
